[Depressive effects of physostigmine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced* / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004644:Emotions / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D010830:Physostigmine / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D012601:Scopolamine / Q000494:pharmacology
D010919:Placebos; D009388:Neostigmine; D010830:Physostigmine; D012601:Scopolamine
Uber die depressogene Wirkung von Physostigmin.